Published in Int J Obes (Lond) on May 22, 2012
Vasopressin: a novel target for the prevention and retardation of kidney disease? Nat Rev Nephrol (2013) 1.26
Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31). Diabetes Care (2013) 0.99
Copeptin and its potential role in diagnosis and prognosis of various diseases. Biochem Med (Zagreb) (2013) 0.91
Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria. Diabetes Care (2013) 0.88
Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial. BMJ Open (2015) 0.85
Dimethylglycine Deficiency and the Development of Diabetes. Diabetes (2015) 0.85
Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community. J Clin Endocrinol Metab (2016) 0.83
Copeptin, Insulin Resistance, and Risk of Incident Diabetes in Older Men. J Clin Endocrinol Metab (2015) 0.83
Sex-dependent pathophysiology as predictors of comorbidity of major depressive disorder and cardiovascular disease. Pflugers Arch (2013) 0.83
Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study. J Am Soc Nephrol (2014) 0.82
Copeptin is an independent predictor of diabetic heart disease and death. Am Heart J (2014) 0.81
Metabolic and Kidney Diseases in the Setting of Climate Change, Water Shortage, and Survival Factors. J Am Soc Nephrol (2016) 0.80
Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome. J Ovarian Res (2014) 0.79
Serum copeptin levels in adolescents with primary hypertension. Pediatr Nephrol (2013) 0.77
Increased Serum Sodium and Serum Osmolarity Are Independent Risk Factors for Developing Chronic Kidney Disease; 5 Year Cohort Study. PLoS One (2017) 0.77
Genetic vasopressin 1b receptor variance in overweight and diabetes mellitus. Eur J Endocrinol (2015) 0.76
Copeptin and Decline in Kidney Function. Am J Nephrol (2016) 0.75
High salt intake increases copeptin but salt sensitivity is associated with fluid induced reduction of copeptin in women. Int J Hypertens (2014) 0.75
Increased copeptin levels in metabolic syndrome from a Romanian population. J Med Life (2016) 0.75
Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study. Diabetologia (2016) 0.75
Reply to the letter to the editor. Eur J Nutr (2016) 0.75
Hypothalamic-pituitary-adrenal axis activity, personality traits, and BCL1 and N363S polymorphisms of the glucocorticoid receptor gene in metabolically obese normal-weight women. Endocrine (2014) 0.75
Atrial natriuretic peptide and type 2 diabetes development--biomarker and genotype association study. PLoS One (2014) 0.75
Plasma copeptin levels are inversely associated with intima-media-thickness in men: the population-based KORA F4 study. Cardiovasc Diabetol (2013) 0.75
Utilization of genetic data can improve the prediction of type 2 diabetes incidence in a Swedish cohort. PLoS One (2017) 0.75
Pathophysiology of copeptin in kidney disease and hypertension. Clin Hypertens (2017) 0.75
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Red cell distribution width, haemoglobin A1c and incidence of diabetes mellitus. J Intern Med (2014) 2.85
Groucho-mediated transcriptional repression establishes progenitor cell pattern and neuronal fate in the ventral neural tube. Cell (2001) 2.70
Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity. J Intern Med (2000) 2.51
Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation (2002) 2.44
Cardiac arrhythmias and stroke: increased risk in men with high frequency of atrial ectopic beats. Stroke (2000) 2.43
Arterial pulse wave velocity with tissue Doppler imaging. Ultrasound Med Biol (2002) 2.36
Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study. Ann Rheum Dis (2008) 2.35
Diabetes, prediabetes and cancer mortality. Diabetologia (2010) 2.22
High levels of cystatin C predict the metabolic syndrome: the prospective Malmö Diet and Cancer Study. J Intern Med (2013) 2.14
Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke. Stroke (2002) 2.11
Red blood cell distribution width is associated with incidence of atrial fibrillation. J Intern Med (2013) 2.10
Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation (2002) 2.09
New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J Intern Med (2010) 2.09
Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug. Nephrol Dial Transplant (2011) 2.04
Incident coronary events and case fatality in relation to common carotid intima-media thickness. J Intern Med (2005) 1.94
Prospective study of prevalence and endoscopic and histopathologic characteristics of duodenal polyps in patients submitted to upper endoscopy. Scand J Gastroenterol (1994) 1.93
Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia (2008) 1.90
Sleep as restitution: an introduction. J Intern Med (2003) 1.77
Alcohol and polyol dehydrogenases are both divided into two protein types, and structural properties cross-relate the different enzyme activities within each type. Proc Natl Acad Sci U S A (1981) 1.74
Structural homologies between prealbumin, gastrointestinal prohormones and other proteins. Nature (1981) 1.69
Geographic distribution of stroke incidence within an urban population: relations to socioeconomic circumstances and prevalence of cardiovascular risk factors. Stroke (2001) 1.67
Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med (2003) 1.64
Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2,511 Finnish adults. Diabetologia (2009) 1.62
Effect of CO2 insufflation on the number and behavior of air microemboli in open-heart surgery: a randomized clinical trial. Circulation (2004) 1.62
Characterization of the humoral immune response in Plasmodium falciparum malaria. II. IgG subclass levels of anti-P. falciparum antibodies in different sera. Clin Exp Immunol (1983) 1.61
Incidence of stroke is related to carotid IMT even in the absence of plaque. Atherosclerosis (2004) 1.60
Incidence of myocardial infarction in elderly men being treated with antihypertensive drugs: population based cohort study. BMJ (1996) 1.60
Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers. Eur J Epidemiol (2000) 1.59
Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8486 primary-care patients. Diabetes Metab (2013) 1.55
Plasma levels of complement C3 is associated with development of hypertension: a longitudinal cohort study. J Hum Hypertens (2006) 1.55
Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population. Int J Obes Relat Metab Disord (2002) 1.52
Food patterns and components of the metabolic syndrome in men and women: a cross-sectional study within the Malmö Diet and Cancer cohort. Am J Epidemiol (2001) 1.51
The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer. Br J Cancer (2008) 1.50
The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions. Diabet Med (2007) 1.49
Ceruloplasmin and atrial fibrillation: evidence of causality from a population-based Mendelian randomization study. J Intern Med (2013) 1.47
Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival. J Intern Med (2014) 1.45
Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int (2006) 1.44
Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat. Am J Physiol (1990) 1.41
Are there differences of inflammatory bio-markers between diabetic and non-diabetic patients with critical limb ischemia? Int Angiol (2006) 1.41
FINAL RESULTS OF GASTRIC RESECTIONS FOR CANCER. Ann Surg (1927) 1.40
Non-invasively detected carotid stenosis and ischaemic heart disease in men with leg arteriosclerosis. Lancet (1993) 1.38
A 16S rRNA-based PCR assay for detection and identification of granulocytic Ehrlichia species in dogs, horses, and cattle. J Clin Microbiol (1996) 1.37
RENAL TUBERCULOSIS: A CLINICAL SURVEY OF 295 CASES, 90 OF WHICH WERE NOT OPERATED ON. Ann Surg (1925) 1.36
Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation (2001) 1.35
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc Natl Acad Sci U S A (2001) 1.34
Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia. Diabetes Obes Metab (2008) 1.33
Urinary concentrating ability: insights from comparative anatomy. Am J Physiol (1985) 1.30
C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. Osteoarthritis Cartilage (2008) 1.30
Association between dietary meat consumption and incident type 2 diabetes: the EPIC-InterAct study. Diabetologia (2012) 1.29
Sleep disturbance in association with elevated pulse rate for prediction of mortality--consequences of mental strain? J Intern Med (2001) 1.29
Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes. J Hum Hypertens (2007) 1.29
Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. Br J Ophthalmol (2009) 1.28
Palatal suture closure in man from 15 to 35 years of age. Am J Orthod (1977) 1.28
The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia (2012) 1.28
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist. J Clin Invest (1996) 1.28
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Functional heterogeneity of leucine pools in human skeletal muscle. Am J Physiol (1997) 1.26
Chronic psychosocial stress predicts long-term cardiovascular morbidity and mortality in middle-aged men. Eur Heart J (2004) 1.24
Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eur J Clin Invest (2006) 1.23
The primary structure of Escherichia coli glutaredoxin. Distant homology with thioredoxins in a superfamily of small proteins with a redox-active cystine disulfide/cysteine dithiol. Eur J Biochem (1983) 1.23
Work-related psychosocial factors and carotid atherosclerosis. Int J Epidemiol (2002) 1.22
Glycerol and nonesterified fatty acid metabolism in human muscle and adipose tissue in vivo. Am J Physiol (1999) 1.19
Occupational status, educational level, and the prevalence of carotid atherosclerosis in a general population sample of middle-aged Swedish men and women: results from the Malmö Diet and Cancer Study. Am J Epidemiol (2000) 1.19
Identification of Serpulina species associated with porcine colitis by biochemical analysis and PCR. J Clin Microbiol (1997) 1.18
Treatment success with a mandibular advancement device is related to supine-dependent sleep apnea. Chest (1998) 1.16
Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register. Diabetes Metab (2007) 1.15
Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet (1987) 1.15
Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab (1999) 1.15
Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes. J Clin Endocrinol Metab (1997) 1.14
The role of movements in the development of sutural and diarthrodial joints tested by long-term paralysis of chick embryos. J Anat (1983) 1.14
Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a study from "men born in 1914," Malmö, Sweden. Circulation (2001) 1.13
Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels. Thyroid (2000) 1.13
Expression of type 1 angiotensin II receptor subtypes and angiotensin II-induced calcium mobilization along the rat nephron. J Am Soc Nephrol (1997) 1.13
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Diabetologia (2011) 1.13
Chronic exposure to vasopressin upregulates ENaC and sodium transport in the rat renal collecting duct and lung. Hypertension (2001) 1.13
The enigma of increased non-cancer mortality after weight loss in healthy men who are overweight or obese. J Intern Med (2002) 1.12
Validation of fractional moving blood volume measurement with power Doppler ultrasound in an experimental sheep model. Ultrasound Obstet Gynecol (2004) 1.11
Oesophageal dysmotility, delayed gastric emptying and autonomic neuropathy correlate to disturbed glucose homeostasis. Diabetologia (2006) 1.11
Ten year cerebrovascular morbidity and mortality in 68 year old men with asymptomatic carotid stenosis. BMJ (1995) 1.11
Efficacy and tolerability of vildagliptin in drug-naïve patients with type 2 diabetes and mild hyperglycaemia*. Diabetes Obes Metab (2007) 1.11
Weight change and mortality: the Nord-Trøndelag Health Study. J Intern Med (2005) 1.11
Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases. Eur J Cardiovasc Prev Rehabil (2007) 1.10
Association between fat intake, physical activity and mortality depending on genetic variation in FTO. Int J Obes (Lond) (2010) 1.10
Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res Clin Pract (2005) 1.09